Literature DB >> 1122765

Histologic type of lung cancer in relation to smoking habits, year of diagnosis and sites of metastases.

O Auerbach, L Garfinkel, V R Parks.   

Abstract

A study was made of histologic type of lung cancer in relation to smoking habit, year of diagnosis, age and sites of metastasis. It comprised 662 autopsies of men during the period from 1955 to 1972. As classified by the WHO system, 35.2 percent were epidermoid carcinoma, 24.6 percent were small cell carcinoma, 25.2 percent were adenocarcinoma and 14.2 percent were large cell undifferentiated carcinoma. The six non-smokers of the series were all found to be in class 3, adenocarcinoma. No clearcut and consistent relationships were observed. Although there was a steady decrease in the incidence of small cell carcinoma during this time period, this observation did not prove to be statistically significant. Small cell carcinomas increased with amount of smoking but not for all age groups. Adenocarcinomas decreased with advancing age but not in all smoking groups. Metastases were found in 96.3 percent of the cases and the sites most frequently involved were regional lymph nodes, liver, brain, distant lymph nodes, adrenals and bone. Small cell carcinomas showed the greatest percentage of involvement for those major sites and for the same sites, epidermoid carcinoma showed the lowest percentage.

Entities:  

Mesh:

Year:  1975        PMID: 1122765     DOI: 10.1378/chest.67.4.382

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

1.  Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types.

Authors:  Matthew D Wilkerson; Xiaoying Yin; Katherine A Hoadley; Yufeng Liu; Michele C Hayward; Christopher R Cabanski; Kenneth Muldrew; C Ryan Miller; Scott H Randell; Mark A Socinski; Alden M Parsons; William K Funkhouser; Carrie B Lee; Patrick J Roberts; Leigh Thorne; Philip S Bernard; Charles M Perou; D Neil Hayes
Journal:  Clin Cancer Res       Date:  2010-07-19       Impact factor: 12.531

2.  Patients presenting with lung cancer in south east Scotland. Edinburgh Lung Cancer Group.

Authors: 
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

3.  Lung cancer in lifelong non-smokers. Edinburgh Lung Cancer Group.

Authors:  S Capewell; R Sankaran; D Lamb; M McIntyre; M F Sudlow
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

Review 4.  The cytopathology of the respiratory tract. A review.

Authors:  W W Johnston; W J Frable
Journal:  Am J Pathol       Date:  1976-08       Impact factor: 4.307

5.  Solitary biceps muscle metastasis from breast cancer.

Authors:  Manar Almusarhed; Hany Eldeeb
Journal:  BMJ Case Rep       Date:  2017-08-20

6.  Lung cancer in a defined geographical area: history and histological types.

Authors:  E Huhti; S Sutinen; A Reinilä; A Poukkula; M Saloheimo
Journal:  Thorax       Date:  1980-09       Impact factor: 9.139

7.  Infiltrative pattern of carcinomatosis in extremity muscles on MRI.

Authors:  Fatima Soliman; Sinchun Hwang; Jonathan Landa; Robert A Lefkowitz; David M Panicek
Journal:  Clin Imaging       Date:  2016-01-15       Impact factor: 1.605

8.  Plumbagin inhibits TPA-induced MMP-2 and u-PA expressions by reducing binding activities of NF-kappaB and AP-1 via ERK signaling pathway in A549 human lung cancer cells.

Authors:  Jiunn-Min Shieh; Tai-An Chiang; Wen-Teng Chang; Chang-Hung Chao; Yi-Chieh Lee; Guan-Yu Huang; You-Xin Shih; Yuan-Wei Shih
Journal:  Mol Cell Biochem       Date:  2009-09-21       Impact factor: 3.396

9.  Variation in smoking-related lung cancer risk factors by cell type among men in Argentina: a case-control study.

Authors:  S M Pezzotto; R Mahuad; M L Bay; J C Morini; L Poletto
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

10.  Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.

Authors:  F Michel; M Solèr; E Imhof; A P Perruchoud
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.